MAST2 and cancer: Overexpression of these fused gene products lead to enhanced proliferation in a benign breast cell line and RNAi-mediated knockdown of MAST2 in a cancer cell line with MAST2 gene fusions led to reduced growth and reduced tumor formation in mice xenografts.